Responsibility is integral to our Company strategy, guiding every aspect of our business to contribute to our mission. We are committed to ensuring that every aspect of our business activities aligns with our sustainability agenda. Our dedication to Environmental, Social, and Governance (ESG) principles is evident through the active support and leadership of our Board of Directors and Board-level committees. The Board has clearly defined our ESG priorities, set strategic direction, and is responsible for monitoring our ESG progress. We are also committed to advancing the Sustainable Development Goals (SDGs), a global framework for promoting a more sustainable future. By aligning our ESG strategy with the SDGs, we ensure that our business activities contribute meaningfully to these global goals.
Specifically, our impact is reflected through eight SDGs that we have identified as material to the success of our business operations, namely:
• We enable greater access to medicine in the region, ensuring patients' rights are upheld. • We provide access to first-line treatment for HIV and Malaria through local manufacturing. • We conduct community health screenings as part of our Corporate Social Responsibility (CSR) efforts.
• Implementation of graduate trainee programmes. • Provision of internship opportunities for pharmacy students. • Support for schools and meritorious students through our CSR initiatives.
• We are an equal opportunity employer. • We are committed to fostering an inclusive workplace.
• Our effluent treatment plant treats 100% of the water generated by the factory, in accordance with the National Environment Management Authority (NEMA) prescribed standards, and 15% of the treated water is reused in our wash areas and to irrigate our green belt.
• We comply with applicable labour laws. • Our comprehensive HR policy supports workers rights and advocates for safe working environments. • We are ISO 45001:2018 Occupational Health and Safety Management System certified.
• We have allocated 20% of our capex towards technologies aimed at enhancing the environmental and social impact of our products and processes.
• We have set a target of reaching zero waste to landfill by 2025. • We monitor toxic elements in our drug substances. • 32% of our waste is recycled, recovered and reused. • We have set targets to reduce our yield losses.
• We actively monitor our climate risk. • We have developed targets and strategies to become carbon neutral by 2030.